SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shasun Pharmaceuticals is currently trading at Rs. 52.15, up by 4.75 points or 10.02% from its previous closing of Rs. 47.40 on the BSE.

The scrip opened at Rs. 48.05 and has touched a high and low of Rs. 53.95 and Rs. 48.05 respectively. So far 139580 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 185.90 on 10-Sep-2012 and a 52 week low of Rs. 45.60 on 26-Jun-2013.

Last one week high and low of the scrip stood at Rs. 57.95 and Rs. 45.60 respectively. The current market cap of the company is Rs. 298.12 crore.

The promoters holding in the company stood at 42.50%, while Institutions and Non-Institutions held 19.88% and 37.62% respectively.

Shasun Pharmaceuticals’ workers at the company’s Pondicherry facility (API and Formulation) have called off the strike and operations have been resumed. The workers have taken this step after reaching at an amicable settlement.

Shasun Pharmaceuticals manufactures active pharmaceutical ingredients (APIs), their intermediates and enteric coating excipients with a significant presence in some key generics. Shasun has created a strong product portfolio, building on its R&D Expertise, regulatory capabilities and multi scale production capacities. It is one of the largest producers of Ibuprofen worldwide.

Peers
Company Name CMP
Sun Pharma Inds. 1669.50
Dr. Reddys Lab 1216.60
Cipla 1239.65
Zydus Lifesciences 928.00
Lupin 2300.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×